Cargando…

The Role of PPARγ in the Cyclooxygenase Pathway in Lung Cancer

Decreased expression of peroxisome proliferator activated receptor-γ (PPARγ) and high levels of the proinflammatory enzyme cyclooxygenase-2 (COX-2) have been observed in many tumor types. Both reduced (PPARγ) expression and elevated COX-2 within the tumor are associated with poor prognosis in lung c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hazra, Saswati, Peebles, Katherine A., Sharma, Sherven, Mao, Jenny T., Dubinett, Steven M.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2008
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526169/ https://www.ncbi.nlm.nih.gov/pubmed/18769553 http://dx.doi.org/10.1155/2008/790568

Ejemplares similares

Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer
por: Baratelli, Felicita, et al.
Publicado: (2008)

Targeting MDSCs enhance therapeutic vaccination responses against lung cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

Cyclooxygenase-2 Inhibitor Parecoxib Was Disclosed as a PPAR-γ Agonist by In Silico and In Vitro Assay
por: Xiao, Bin, et al.
Publicado: (2021)

PPAR Gamma and Hepatic Stellate Cells
por: Hazra, Saswati, et al.
Publicado: (2004)

A Role for the PPARγ in Cancer Therapy
por: Campbell, Moray J., et al.
Publicado: (2008)

The role and function of PPARγ in bladder cancer
por: Peng, Tianchen, et al.
Publicado: (2020)

Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth
por: Kar, Upendra K., et al.
Publicado: (2011)

The Role of PPARγ in Hepatocellular Carcinoma
por: Borbath, Ivan, et al.
Publicado: (2008)

The Role of PPAR-γ in Allergic Disease
por: Stark, Julian M., et al.
Publicado: (2021)

Current Understanding of the Role of PPARγ in Gastrointestinal Cancers
por: Zou, Bing, et al.
Publicado: (2009)

Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer
por: Chiu, Melody, et al.
Publicado: (2017)

The role of PPARγ in prostate cancer development and progression
por: Hartley, Andrew, et al.
Publicado: (2022)

The role of PPARγ in carbon nanotube-elicited granulomatous lung inflammation
por: Huizar, Isham, et al.
Publicado: (2013)

PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008)

Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

PPARγ as a Novel Therapeutic Target in Lung Cancer
por: Reddy, Aravind T., et al.
Publicado: (2016)

PPARγ sumoylation-mediated lipid accumulation in lung cancer
por: Phan, Ai N.H., et al.
Publicado: (2017)

IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer
por: Kachroo, Puja, et al.
Publicado: (2013)

PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis
por: Wu, Lujin, et al.
Publicado: (2019)

Bronchopulmonary Dysplasia: Crosstalk Between PPARγ, WNT/β-Catenin and TGF-β Pathways; The Potential Therapeutic Role of PPARγ Agonists
por: Lecarpentier, Yves, et al.
Publicado: (2019)

SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10
por: Sharma, Sherven, et al.
Publicado: (2003)

Correction: Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer
por: Srivastava, Minu K, et al.
Publicado: (2012)

The Roles of Dietary PPARγ Ligands for Metastasis in Colorectal Cancer
por: Kuniyasu, Hiroki
Publicado: (2008)

Thiazolidinediones on PPARγ: The Roles in Bone Remodeling
por: Wei, Wei, et al.
Publicado: (2011)

Role of PPARγ in the Differentiation and Function of Neurons
por: Quintanilla, Rodrigo A., et al.
Publicado: (2014)

PPARγ and Its Role in Cardiovascular Diseases
por: Chandra, Mini, et al.
Publicado: (2017)

Dysregulation of the Amniotic PPARγ Pathway by Phthalates: Modulation of the Anti-Inflammatory Activity of PPARγ in Human Fetal Membranes
por: Antoine, Audrey, et al.
Publicado: (2022)

Correction: PPARγ sumoylation-mediated lipid accumulation in lung cancer
por: Phan, Ai N.H., et al.
Publicado: (2019)

The CD36-PPARγ Pathway in Metabolic Disorders
por: Maréchal, Loïze, et al.
Publicado: (2018)

Lysophospholipid-Related Diseases and PPARγ Signaling Pathway
por: Tsukahara, Tamotsu, et al.
Publicado: (2017)

PPARγ and MEK Interactions in Cancer
por: Burgermeister, Elke, et al.
Publicado: (2008)

PPARγ and Proline Oxidase in Cancer
por: Phang, James M., et al.
Publicado: (2008)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

PD-1 Immune Checkpoint Blockade Promotes Therapeutic Cancer Vaccine to Eradicate Lung Cancer
por: Kadam, Pournima, et al.
Publicado: (2020)

Role of the Cyclooxygenase Pathway in the Association of Obstructive Sleep Apnea and Cancer
por: Picado, César, et al.
Publicado: (2020)

The Role of PPAR-γ and Its Interaction with COX-2 in Pancreatic Cancer
por: Eibl, Guido
Publicado: (2008)

A Role for PPARγ in the Regulation of Cytokines in Immune Cells and Cancer
por: Yang, Xiao Yi, et al.
Publicado: (2008)

The Role of the PAX8/PPARγ Fusion Oncogene in Thyroid Cancer
por: Placzkowski, Kimberly A., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ho2m1gs7od282a15tsjhp1d6o6